Niva Bupa Health Insurance Company Limited (NSE:NIVABUPA)
India
· Delayed Price · Currency is INR 77.79
+0.74 (0.96%)
Feb 21, 2025, 9:15 AM IST
NSE:NIVABUPA Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Premiums & Annuity Revenue | 45,851 | 38,112 | 26,628 | 17,525 | 11,509 | 8,411 | Upgrade
|
| Total Interest & Dividend Income | 4,217 | 2,919 | 1,862 | 1,228 | 863.99 | 623.87 | Upgrade
|
| Gain (Loss) on Sale of Investments | 72.07 | 72.07 | 49.4 | 262.54 | 60.4 | -101.63 | Upgrade
|
| Other Revenue | 2,604 | 2,225 | 3,641 | 2,677 | 1,724 | 1,494 | Upgrade
|
| Total Revenue | 52,743 | 43,328 | 32,180 | 21,693 | 14,157 | 10,427 | Upgrade
|
| Revenue Growth (YoY) | 32.19% | 34.64% | 48.35% | 53.23% | 35.77% | 23.57% | Upgrade
|
| Policy Benefits | 27,490 | 22,495 | 14,393 | 10,886 | 6,456 | 4,501 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 10,201 | 7,482 | 1,908 | 1,204 | 634.81 | 428.76 | Upgrade
|
| Selling, General & Administrative | 10,395 | 10,092 | 11,842 | 8,598 | 5,454 | 4,246 | Upgrade
|
| Provision for Bad Debts | 14.53 | 18.13 | 10.25 | 221.71 | 283.45 | 350 | Upgrade
|
| Other Operating Expenses | 2,393 | 2,154 | 3,634 | 2,681 | 1,765 | 1.83 | Upgrade
|
| Total Operating Expenses | 50,744 | 42,241 | 31,787 | 23,591 | 14,592 | 9,528 | Upgrade
|
| Operating Income | 1,999 | 1,088 | 393.04 | -1,899 | -435.46 | 899.65 | Upgrade
|
| Interest Expense | -267.5 | -267.5 | -267.5 | -65.23 | -59.38 | -40.84 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.58 | -1.58 | -0.14 | -1.27 | -2.54 | -0.78 | Upgrade
|
| Other Non Operating Income (Expenses) | -84.6 | - | - | 0.01 | -0 | -1,474 | Upgrade
|
| EBT Excluding Unusual Items | 1,645 | 818.52 | 125.4 | -1,965 | -497.39 | -615.52 | Upgrade
|
| Pretax Income | 1,645 | 818.52 | 125.4 | -1,965 | -497.39 | -615.52 | Upgrade
|
| Net Income | 1,645 | 818.52 | 125.4 | -1,965 | -497.39 | -615.52 | Upgrade
|
| Net Income to Common | 1,645 | 818.52 | 125.4 | -1,965 | -497.39 | -615.52 | Upgrade
|
| Net Income Growth | - | 552.73% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 1,810 | 1,590 | 1,463 | 1,387 | 1,163 | 1,065 | Upgrade
|
| Shares Outstanding (Diluted) | 1,851 | 1,631 | 1,503 | 1,389 | 1,163 | 1,070 | Upgrade
|
| Shares Change (YoY) | 22.79% | 8.55% | 8.20% | 19.40% | 8.75% | 13.25% | Upgrade
|
| EPS (Basic) | 0.91 | 0.51 | 0.09 | -1.42 | -0.43 | -0.58 | Upgrade
|
| EPS (Diluted) | 0.89 | 0.50 | 0.08 | -1.42 | -0.43 | -0.58 | Upgrade
|
| EPS Growth | - | 525.00% | - | - | - | - | Upgrade
|
| Free Cash Flow | - | 7,796 | 5,547 | 3,090 | 2,287 | 772.03 | Upgrade
|
| Free Cash Flow Per Share | - | 4.78 | 3.69 | 2.22 | 1.97 | 0.72 | Upgrade
|
| Operating Margin | 3.79% | 2.51% | 1.22% | -8.75% | -3.08% | 8.63% | Upgrade
|
| Profit Margin | 3.12% | 1.89% | 0.39% | -9.06% | -3.51% | -5.90% | Upgrade
|
| Free Cash Flow Margin | - | 17.99% | 17.24% | 14.25% | 16.16% | 7.40% | Upgrade
|
| EBITDA | 2,102 | 1,186 | 485.93 | -1,810 | -214.93 | 1,106 | Upgrade
|
| EBITDA Margin | 3.98% | 2.74% | 1.51% | -8.34% | -1.52% | 10.61% | Upgrade
|
| D&A For EBITDA | 103.02 | 98.68 | 92.89 | 88.67 | 220.53 | 206.68 | Upgrade
|
| EBIT | 1,999 | 1,088 | 393.04 | -1,899 | -435.46 | 899.65 | Upgrade
|
| EBIT Margin | 3.79% | 2.51% | 1.22% | -8.75% | -3.08% | 8.63% | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.